Other
Reviewed and published by trentmaziarz, July 9, 2026. Discovered and drafted by our automated research pipeline.
Boston Scientific uses an internal AI-based omnichannel sales and marketing platform that analyzes data to deliver targeted educational messages and product information to physicians through the most relevant channel at the optimal time. Company executives publicly described this initiative at a February 2024 investor event.
Details
The omnichannel platform aggregates customer touchpoint data from multiple channels (digital, in-person, events) and uses AI to determine what content to deliver to which physician, through which channel, and when. According to Boston Scientific group president Art Butcher, the platform is designed to reduce 'unnecessary duplication' in sales and marketing outreach while improving customer experience and sales representative efficiency. The company describes this as an internal commercial operations tool, not a customer-facing product.
Products affected
Boston Scientific Omnichannel Sales & Marketing Platform
Sources & Evidence
Cite this record
Trace Foundation. (2026). Boston Scientific: Boston Scientific uses an internal AI-based omnichannel sales and marketing platform that analyzes data to deliver targeted educational messages and product information to physicians through the most relevant channel at the optimal time. Company executives publicly described this initiative at a February 2024 investor event (data as of 2026-07-09) [Data set record]. AI Trace. https://www.aitrace.org/r/practice/758bd6ea-3242-4538-8313-c600f1c2c761. Accessed October 7, 2026.
- Stable link
- https://www.aitrace.org/r/practice/758bd6ea-3242-4538-8313-c600f1c2c761
- Data as of
- July 9, 2026
- Last verified
- August 4, 2026
Other practices by Boston Scientific
RecommendationBoston Scientific integrated Coveo's AI-search platform into its B2B e-commerce site to deliver personalized search results, relevance tuning, and behavior-based product recommendations for healthcare facility buyers and sales representatives. The integration has been underway for approximately four years.Data AnalysisBoston Scientific deployed the AVVIGO+ Multi-Modality Guidance System, which includes an AI software feature called Automated Lesion Assessment that automatically identifies and measures coronary artery blockages during heart procedures. The system received FDA clearance in September 2023.Data AnalysisBoston Scientific deployed BeatLogic, a deep-learning algorithm that automatically analyzes ECG data from cardiac monitoring devices to detect and classify 34 distinct arrhythmias. The system processes over 3 billion heartbeats daily across patients in the United States and sends critical alerts to physicians.
Have evidence about Boston Scientific's AI practices? Submit a report.
Report a Sighting →